The study will assess patient characteristics, treatment patterns, and outcomes in patients treated with DMARDs, including biological, conventional, and targeted synthetic DMARDs, in Finland.
The objectives of the study are to:
1) report patient numbers and characteristics of DMARD-treated patients,
2) describe, predict, and compare treatment patterns in DMARD-treated patients, and
3) study and compare patient outcomes related to e.g., costs and (comparative) safety and effectiveness of DMARDs
Lupaan tehdyt muutokset: Tietojen (esim. muuttujien) lisääminen